NHS National Pharmaceuticals Transition 2022_1
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-03233832014L0024closed for bids
Estimated value
£468.0m
goods
Awarded value
—
Suppliers
0
Lots
3
0 awarded
Published
17 Mar 2022
Deadline 21 Apr 2022
Description
NHS National Pharmaceuticals Transition 2022_1<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: <br/>CESW: 29/07/2022 to 30/09/2023 (14 months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22 months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6 months)<br/><br/>Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months)<br/><br/>Hospital Only Products: <br/>CESW: 29/07/2022 to 30/09/2023 (14 months)<br/>LSNE: 29/07/2022 to 31/05/2024 (22 months)<br/>NWLN: 29/07/2022 to 31/01/2023 (6 months)
Scope
- Reference
- CM/PHG/21/5637
- Total value
- £467,969,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2022 to 31 May 2024
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- UK
Submission & procedure
- Submission deadline
- 21 Apr 2022, 12:00 pm
- Submission address
- http://health.atamis.co.uk ↗
- Procedure
- Open procedure
Lots · 3 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 - CM/PHG/21/5637/00 Transition products | £397.8m | active |
| 2 | Lot 2 - CM/PHG/21/5637/01 Oral (plus non-parenteral) Products | £12.3m | active |
| 3 | Lot 3 - CM/PHG/21/5637/02 Hospital Only Products | £57.9m | active |